recorded total sales revenue of THB 733.57 million and THB 384.43 million respectively. This equals to a sharp decline of 47.59% year on year. Domestic sales revenue dropped 46.25% from the same period of
, the Company recorded total sales revenue of THB 983.36 million and THB 557.33 million respectively. This equals to a sharp decline of 4 3.32% year on year. Domestic sales revenue dropped 43.28% from the
sector, with manufacturing and industrial sectors suffering a sharp contraction. In order to mitigate the economic impact, the Government and other institutions have introduced relief measures to help
under trademark “Wuttisak Clinic” the Company has change the business strategy for appropriate with the business environment by closed 7 departments which have accumulate loss in July 2019 and decreased
% EBITDA margin (%) 27.3% 27.9% NNP margin (%) 9.7% 9.5% % NNP - Owner of the parent 58.6% 59.1% Remark: *Normalized net profit = Net profit – Unrealized gain (loss) from FX – Non-recurring income / (expense
profit 427.9 354.5 73.4 20.7 Net gain (loss) on exchange rate 112.2 (28.3) 140.5 N.A. (>100) Gain on forward contracts 49.5 - 49.5 N.A. (>100) Other income 173.0 14.1 158.9 1,127.0 Profit before expenses
administration expense • Reported net loss of THB 238mn, largely as a result of the aforementioned reasons above • Total assets as of 31 March 2019 stood at THB 53,181mn, decreased by 1.4% or THB 779mn from 31
ตาม หลักเกณฑของธุรกิจของผูประกอบธุรกิจหลักทรัพยท่ีมีการใหบริการแผนการลงทุนในลักษณะ portfolio2 (2) การกําหนดอัตราขาดทุนสูงสุด (stop-loss limit) ผูประกอบธุรกิจสามารถเลือกกําหนด stop-loss limit ของ
(1,117.11) (36.7) 4,796.69 5,877.35 (1,080.66) (18.4) Gain (Loss) on FX 541.72 (223.68) 765.40 342.2 (81.31) (185.65) 104.34 56.2 Profit to owner of the Company 1,074.16 1,952.31 (878.15) (45.0) 2,434.98
beginning of this year, the Company had gain on exchange rate while the Thai Baht value appreciated against US Dollar and the Company had loss on exchange rate in last year As a result of above reason, the